These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

802 related items for PubMed ID: 9426064

  • 1. Inhibition of DNA methylation by 5-aza-2'-deoxycytidine suppresses the growth of human tumor cell lines.
    Bender CM, Pao MM, Jones PA.
    Cancer Res; 1998 Jan 01; 58(1):95-101. PubMed ID: 9426064
    [Abstract] [Full Text] [Related]

  • 2. Cell division is required for de novo methylation of CpG islands in bladder cancer cells.
    Velicescu M, Weisenberger DJ, Gonzales FA, Tsai YC, Nguyen CT, Jones PA.
    Cancer Res; 2002 Apr 15; 62(8):2378-84. PubMed ID: 11956100
    [Abstract] [Full Text] [Related]

  • 3. Increased expression of unmethylated CDKN2D by 5-aza-2'-deoxycytidine in human lung cancer cells.
    Zhu WG, Dai Z, Ding H, Srinivasan K, Hall J, Duan W, Villalona-Calero MA, Plass C, Otterson GA.
    Oncogene; 2001 Nov 22; 20(53):7787-96. PubMed ID: 11753657
    [Abstract] [Full Text] [Related]

  • 4. Re-expression of p16 gene in the myeloma cell line U266 induced by synergy of sodium butyrate and 5-Aza-2'-deoxycytidine.
    Du HL, Ren LM, Chen H, Zhu Y, Qi Y.
    Di Yi Jun Yi Da Xue Xue Bao; 2002 Nov 22; 22(11):981-4. PubMed ID: 12433622
    [Abstract] [Full Text] [Related]

  • 5. Activation of the p53 DNA damage response pathway after inhibition of DNA methyltransferase by 5-aza-2'-deoxycytidine.
    Karpf AR, Moore BC, Ririe TO, Jones DA.
    Mol Pharmacol; 2001 Apr 22; 59(4):751-7. PubMed ID: 11259619
    [Abstract] [Full Text] [Related]

  • 6. Inhibition of histone deacetylation does not block resilencing of p16 after 5-aza-2'-deoxycytidine treatment.
    Egger G, Aparicio AM, Escobar SG, Jones PA.
    Cancer Res; 2007 Jan 01; 67(1):346-53. PubMed ID: 17210717
    [Abstract] [Full Text] [Related]

  • 7. Reactivation of tumor suppressor genes by the cardiovascular drugs hydralazine and procainamide and their potential use in cancer therapy.
    Segura-Pacheco B, Trejo-Becerril C, Perez-Cardenas E, Taja-Chayeb L, Mariscal I, Chavez A, Acuña C, Salazar AM, Lizano M, Dueñas-Gonzalez A.
    Clin Cancer Res; 2003 May 01; 9(5):1596-603. PubMed ID: 12738711
    [Abstract] [Full Text] [Related]

  • 8. [Growth inhibition effect of 5-aza-CdR on endometrial carcinoma xenografted in nude mice by p16 gene demethylation].
    Chao H, Sun J, Lu S.
    Zhonghua Fu Chan Ke Za Zhi; 2000 Apr 01; 35(4):229-32. PubMed ID: 11776167
    [Abstract] [Full Text] [Related]

  • 9. 5-aza-2'-deoxycytidine induces retinoic acid receptor beta 2 demethylation, cell cycle arrest and growth inhibition in breast carcinoma cells.
    Yang Q, Shan L, Yoshimura G, Nakamura M, Nakamura Y, Suzuma T, Umemura T, Mori I, Sakurai T, Kakudo K.
    Anticancer Res; 2002 Apr 01; 22(5):2753-6. PubMed ID: 12529992
    [Abstract] [Full Text] [Related]

  • 10. 5-Aza-2'-deoxycytidine enhances maspin expression and inhibits proliferation, migration, and invasion of the bladder cancer T24 cell line.
    Zhang H, Qi F, Cao Y, Zu X, Chen M, Li Z, Qi L.
    Cancer Biother Radiopharm; 2013 May 01; 28(4):343-50. PubMed ID: 23570371
    [Abstract] [Full Text] [Related]

  • 11. Study of 5-Aza-CdR on transcription regulation of RASSF1A gene in the BIU87 cell line.
    Liu X, Dai X, Wu B.
    Urol Int; 2009 May 01; 82(1):108-12. PubMed ID: 19172108
    [Abstract] [Full Text] [Related]

  • 12. [Apoptosis and re-expression of p16 gene in the myeloma cell line U266 induced by synergy of histone deacetylase inhibitor and demethylating agent].
    Du HL, Qi Y, Shi YJ, Bu DF, Wu SL.
    Ai Zheng; 2002 Oct 01; 21(10):1057-61. PubMed ID: 12508642
    [Abstract] [Full Text] [Related]

  • 13. [The study of 5-Aza-2'-deoxycytidine on transcription regulation of p16/CDKN2 gene demethylation in RKO human colorectal cell line].
    Fang XM, Sun LF, Peng JP, Dong Q, Zheng S.
    Zhonghua Yi Xue Za Zhi; 2003 Dec 10; 83(23):2077-82. PubMed ID: 14703421
    [Abstract] [Full Text] [Related]

  • 14. Analysis of gene induction in human fibroblasts and bladder cancer cells exposed to the methylation inhibitor 5-aza-2'-deoxycytidine.
    Liang G, Gonzales FA, Jones PA, Orntoft TF, Thykjaer T.
    Cancer Res; 2002 Feb 15; 62(4):961-6. PubMed ID: 11861364
    [Abstract] [Full Text] [Related]

  • 15. Methylation-associated silencing of death-associated protein kinase gene in laryngeal squamous cell cancer.
    Kong WJ, Zhang S, Guo C, Zhang S, Wang Y, Zhang D.
    Laryngoscope; 2005 Aug 15; 115(8):1395-401. PubMed ID: 16094112
    [Abstract] [Full Text] [Related]

  • 16. Deletional, mutational, and methylation analyses of CDKN2 (p16/MTS1) in primary and metastatic prostate cancer.
    Jarrard DF, Bova GS, Ewing CM, Pin SS, Nguyen SH, Baylin SB, Cairns P, Sidransky D, Herman JG, Isaacs WB.
    Genes Chromosomes Cancer; 1997 Jun 15; 19(2):90-6. PubMed ID: 9171999
    [Abstract] [Full Text] [Related]

  • 17. Hepatocyte growth factor activator inhibitor 2/placental bikunin (HAI-2/PB) gene is frequently hypermethylated in human hepatocellular carcinoma.
    Fukai K, Yokosuka O, Chiba T, Hirasawa Y, Tada M, Imazeki F, Kataoka H, Saisho H.
    Cancer Res; 2003 Dec 15; 63(24):8674-9. PubMed ID: 14695180
    [Abstract] [Full Text] [Related]

  • 18. The role of DNA methylation in expression of the p19/p16 locus in human bladder cancer cell lines.
    Gonzalgo ML, Hayashida T, Bender CM, Pao MM, Tsai YC, Gonzales FA, Nguyen HD, Nguyen TT, Jones PA.
    Cancer Res; 1998 Mar 15; 58(6):1245-52. PubMed ID: 9515812
    [Abstract] [Full Text] [Related]

  • 19. Histone H3-lysine 9 methylation is associated with aberrant gene silencing in cancer cells and is rapidly reversed by 5-aza-2'-deoxycytidine.
    Nguyen CT, Weisenberger DJ, Velicescu M, Gonzales FA, Lin JC, Liang G, Jones PA.
    Cancer Res; 2002 Nov 15; 62(22):6456-61. PubMed ID: 12438235
    [Abstract] [Full Text] [Related]

  • 20. Limited gene activation in tumor and normal epithelial cells treated with the DNA methyltransferase inhibitor 5-aza-2'-deoxycytidine.
    Karpf AR, Lasek AW, Ririe TO, Hanks AN, Grossman D, Jones DA.
    Mol Pharmacol; 2004 Jan 15; 65(1):18-27. PubMed ID: 14722233
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 41.